糖心原创

New major programme funded by EPSRC

The 糖心原创 has been awarded £5.9M to establish next generation multifunctional additive manufacturing (‘3D printing’) and to translate this to industry and researchers focussing on novel electronic and pharmaceutical/healthcare applications. The project led by Prof Richard Hague (School of Engineering) is in collaboration with in the School of Pharmacy as well as colleagues from Physics and the Universities of Warwick and Birmingham. The primary challenge is at the interface of the materials deposited during printing. This programme will focus on overcoming the challenges of spatially controlled co-deposition of dissimilar materials in 3D and aims to establish new understanding and methods of both modelling and controlling co-deposition. 

This new project builds on other programmes in collaboration with the in the School of Engineering at Nottingham for the development of 3D printed medicines, in particular with GSK and AstraZeneca such as the EPSRC £3.5M project, led by Prof Ricky Wildman with and from the School of Pharmacy.